Cyanotech Corp

CYAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $24.2M $23.1M $23.2M $36.0M $32.3M $31.9M $30.2M $34.1M
Cost of Revenue $17.3M $17.1M $15.9M $22.4M $21.2M $19.2M $19.7M $20.7M
Gross Profit $6.9M $5.9M $7.3M $13.6M $11.1M $12.7M $10.5M $13.4M
Gross Margin 28.4% 25.8% 31.3% 37.7% 34.4% 39.8% 34.7% 39.2%
Operating Expenses
Research & Development $449.0K $689.0K $770.0K $712.0K $639.0K $608.0K $923.0K $563.0K
SG&A Expense $4.4M $4.5M $4.7M $5.4M $4.9M $5.3M $5.7M $5.0M
Operating Income $-2.5M $-4.6M $-2.9M $2.6M $84.0K $1.1M $-3.0M $1.4M
Operating Margin -10.4% -19.9% -12.6% 7.2% 0.3% 3.3% -9.9% 4.1%
Interest Expense $687.0K $668.0K $502.0K $392.0K $550.0K $657.0K $582.0K $499.0K
Pretax Income $-3.2M $-5.3M $-3.4M $2.2M $923.0K $396.0K $-3.6M $915.0K
Income Tax Expense $8.0K $7.0K $18.0K $28.0K $3.0K $9.0K $17.0K $-110.0K
Net Income $-3.2M $-5.3M $-3.4M $2.2M $920.0K $387.0K $-3.6M $1.0M
Net Margin -13.2% -22.8% -14.8% 6.0% 2.8% 1.2% -11.9% 3.0%
EPS (Basic) $-0.45 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 7.1M 7.07B 6.76B 6.67B 6.57B 6.45B 6.30B 6.18B
Shares Outstanding (Diluted) 7.1M 7.1M 6.76B 6.68B 6.58B 6.45B 6.30B 6.26B
Dividends Per Share
← Newer Page 1 of 2 Older →